Opus Genetics officer plans $125K stock sale

Opus Genetics officer Robert E. Gagnon files a Rule 144 notice to sell shares mainly to cover tax withholding from vested RSUs.

Rhea-AI Filing Summary

Opus Genetics, Inc. (IRD) is the issuer for a planned sale of common stock under Rule 144 by officer Robert E. Gagnon28,000 shares of common stocktax withholding obligations7,783 shares$22,941.72 during the past three months is also disclosed.

Key Figures

Shares to be sold under Rule 144: 28,000 shares Aggregate value of planned sale: $124,600.00 Recent shares sold in past 3 months: 7,783 shares +1 more

4 metrics

Shares to be sold under Rule 144 28,000 shares Common stock of Opus Genetics, Inc. listed with Jefferies LLC as broker

Aggregate value of planned sale $124,600.00 Listed for the 28,000 Opus Genetics common shares in the Rule 144 notice

Recent shares sold in past 3 months 7,783 shares Shares of Opus Genetics, Inc. sold on July 23, 2026 by Robert E. Gagnon

Proceeds from recent sale $22,941.72 Consideration for 7,783 Opus Genetics shares sold on July 23, 2026

Key Terms

Rule 144, Vested Restricted Stock Units, tax withholding obligations

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Vested Restricted Stock Units financial

"Common | 09/10/2025 | Vested Restricted Stock Units | Opus Genetics, Inc."

tax withholding obligations financial

"required by the Company to satisfy tax withholding obligations that arose"

FAQ

What does the Form 144 filing report for Opus Genetics, Inc. (IRD)?

It reports that officer Robert E. GagnonRule 144 to sell up to 28,000 sharestax withholding obligations

How many Opus Genetics (IRD) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of up to 28,000 shares of common stockvested restricted stock unitstax withholding obligations

What proceeds are associated with the planned Rule 144 sale for Opus Genetics (IRD)?

The filing lists an aggregate value of $124,600.0028,000 shares

Were there any recent Opus Genetics (IRD) share sales by the same person?

Yes. The filing discloses that 7,783 sharesJuly 23, 2026$22,941.72 by Robert E. Gagnon during the prior three months.

Is the planned Opus Genetics (IRD) share sale a discretionary trade by the officer?

No. The remarks state that the shares are to be sold automaticallytax withholding obligations

Which broker is named for the Opus Genetics (IRD) Rule 144 sale?

The filing identifies Jefferies LLC28,000 shares

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:17 PM Accepted by SEC EDGAR 09/03/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001504983
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Opus Genetics, Inc.
SEC File Number	001-34079
Address of Issuer	8 DAVIS DRIVE SUITE 220 DURHAM NORTH CAROLINA 27713
Phone	(984) 884-6030
Name of Person for Whose Account the Securities are To Be Sold	Gagnon Robert E.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Ave New York NY 10022	28000	124600.00	83200000	09/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2025	Vested Restricted Stock Units	Opus Genetics, Inc.			28000	09/10/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert E Gagnon 8 Davis Drive Ste. 220 Durham NC 27709	Opus Genetics, Inc.	07/23/2026	7783	22941.72

144: Remarks and Signature

Remarks	Shares to be sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a RSU award. This transaction will not represent a discretionary trade by the Reporting Person.
Date of Notice	09/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Robert Gagnon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)